JP2021521149A5 - - Google Patents
Info
- Publication number
- JP2021521149A5 JP2021521149A5 JP2020555339A JP2020555339A JP2021521149A5 JP 2021521149 A5 JP2021521149 A5 JP 2021521149A5 JP 2020555339 A JP2020555339 A JP 2020555339A JP 2020555339 A JP2020555339 A JP 2020555339A JP 2021521149 A5 JP2021521149 A5 JP 2021521149A5
- Authority
- JP
- Japan
- Prior art keywords
- universal
- seq
- vaccine composition
- composition according
- liposome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025015003A JP2025084745A (ja) | 2018-04-10 | 2025-01-31 | 抗－ａベータ治療用ワクチン |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18166659 | 2018-04-10 | ||
| EP18166659.5 | 2018-04-10 | ||
| EP18202366.3 | 2018-10-24 | ||
| EP18202366 | 2018-10-24 | ||
| PCT/EP2019/058980 WO2019197414A1 (en) | 2018-04-10 | 2019-04-09 | Anti-abeta therapeutic vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025015003A Division JP2025084745A (ja) | 2018-04-10 | 2025-01-31 | 抗－ａベータ治療用ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521149A JP2021521149A (ja) | 2021-08-26 |
| JP2021521149A5 true JP2021521149A5 (enExample) | 2022-04-15 |
| JP7713213B2 JP7713213B2 (ja) | 2025-07-25 |
Family
ID=66092353
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555339A Active JP7713213B2 (ja) | 2018-04-10 | 2019-04-09 | 抗－ａベータ治療用ワクチン |
| JP2025015003A Pending JP2025084745A (ja) | 2018-04-10 | 2025-01-31 | 抗－ａベータ治療用ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025015003A Pending JP2025084745A (ja) | 2018-04-10 | 2025-01-31 | 抗－ａベータ治療用ワクチン |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10828351B2 (enExample) |
| EP (1) | EP3773712A1 (enExample) |
| JP (2) | JP7713213B2 (enExample) |
| KR (2) | KR102869640B1 (enExample) |
| AU (1) | AU2019253193B2 (enExample) |
| BR (1) | BR112020020660A2 (enExample) |
| CA (1) | CA3095983A1 (enExample) |
| CL (1) | CL2020002586A1 (enExample) |
| CO (1) | CO2020013977A2 (enExample) |
| CR (1) | CR20200533A (enExample) |
| IL (1) | IL277851B2 (enExample) |
| MA (1) | MA52180A (enExample) |
| MX (1) | MX2020010621A (enExample) |
| MY (1) | MY206040A (enExample) |
| PE (1) | PE20201344A1 (enExample) |
| PH (1) | PH12020551670A1 (enExample) |
| SG (1) | SG11202009917PA (enExample) |
| TW (1) | TWI908707B (enExample) |
| WO (1) | WO2019197414A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA52180A (fr) * | 2018-04-10 | 2021-02-17 | Ac Immune Sa | Vaccins thérapeutiques anti-abêta |
| CN113853214A (zh) * | 2019-05-21 | 2021-12-28 | Ac免疫有限公司 | 抗Aβ疫苗治疗 |
| IL314865A (en) * | 2022-02-09 | 2024-10-01 | Ac Immune Sa | Anti-alpha-synuclein therapeutic vaccines |
| WO2024156912A1 (en) * | 2023-01-26 | 2024-08-02 | Ac Immune Sa | Anti-abeta vaccine therapy |
| KR20250135293A (ko) | 2023-01-26 | 2025-09-12 | 에이씨 이뮨 에스에이 | 리포좀 구조체 |
| WO2025109524A1 (en) | 2023-11-22 | 2025-05-30 | Ac Immune Sa | Assays and methods for assessing vaccine preparations |
| WO2025196262A1 (en) | 2024-03-22 | 2025-09-25 | Ac Immune Sa | Immunoassay involving antibodies binding vaccine adjuvants |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001062284A2 (en) | 2000-02-21 | 2001-08-30 | Pharmexa A/S | Novel method for down-regulation of amyloid |
| IL157475A0 (en) | 2001-02-20 | 2004-03-28 | Pharmexa As | Synthetic vaccines comprising polyhydroxypolymer carriers |
| MY144532A (en) | 2001-08-20 | 2011-09-30 | Lundbeck & Co As H | Novel method for down-regulation of amyloid |
| CA2493119A1 (en) | 2002-07-17 | 2004-01-22 | Mindset Biopharmaceuticals Usa Inc. | Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease |
| US20060276400A1 (en) | 2005-06-06 | 2006-12-07 | Hedy Adari | Modulation of cholesteryl ester transfer protein (CETP) activity |
| CA2633399C (en) | 2005-12-12 | 2016-01-26 | Ac Immune S.A. | Therapeutic vaccine |
| CN101421299A (zh) | 2006-02-22 | 2009-04-29 | 株式会社林原生物化学研究所 | 用于诱导产生抗淀粉样β肽抗体的肽疫苗 |
| EP1997067A4 (en) * | 2006-03-01 | 2011-06-01 | Tag Llc | METHOD FOR SELECTING A COMPETITIVE MEDICAL PRESCRIPTION PROVIDER AND / OR COMPETITIVE CALL SERVICE |
| EA026787B1 (ru) | 2007-08-27 | 2017-05-31 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Конструкция нуклеиновой кислоты и ее применение для лечения, предотвращения и сдерживания болезни альцгеймера |
| EP2231180B1 (en) * | 2008-01-16 | 2016-08-17 | Ben-gurion University Of The Negev Research And Development Authority | Vaccine for alzheimer's disease |
| CA2723918C (en) * | 2008-06-05 | 2018-01-09 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| US9498522B2 (en) | 2008-08-07 | 2016-11-22 | Mercia Pharma Inc. | Immunotherapeutic compositions for the treatment of alzheimer'S disease |
| CN107617110A (zh) | 2009-08-26 | 2018-01-23 | 西莱克塔生物科技公司 | 诱导t细胞辅助的组合物 |
| WO2011115483A1 (en) | 2010-03-15 | 2011-09-22 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| WO2012020124A1 (en) | 2010-08-12 | 2012-02-16 | Ac Immune S.A. | Vaccine engineering |
| EP2632434B1 (en) * | 2010-10-26 | 2025-08-20 | AC Immune S.A. | Liposome-based construct comprising a peptide modified through hydrophobic moieties |
| IN2014CN02581A (enExample) * | 2011-10-06 | 2015-08-07 | Immunovaccine Technologies Inc | |
| US9102752B2 (en) | 2013-03-15 | 2015-08-11 | United Biomedical, Inc. | Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type |
| MA40824A (fr) | 2014-10-22 | 2017-08-29 | Saiba Gmbh | Particules de cmv de type virus modifié |
| CN105418767B (zh) | 2015-12-22 | 2019-03-08 | 云南大学 | 一种用于制备Aβ表位疫苗的融合蛋白及其制备方法和用途 |
| MA52180A (fr) * | 2018-04-10 | 2021-02-17 | Ac Immune Sa | Vaccins thérapeutiques anti-abêta |
-
2019
- 2019-04-09 MA MA052180A patent/MA52180A/fr unknown
- 2019-04-09 SG SG11202009917PA patent/SG11202009917PA/en unknown
- 2019-04-09 JP JP2020555339A patent/JP7713213B2/ja active Active
- 2019-04-09 CA CA3095983A patent/CA3095983A1/en active Pending
- 2019-04-09 TW TW108112384A patent/TWI908707B/zh active
- 2019-04-09 EP EP19716161.5A patent/EP3773712A1/en active Pending
- 2019-04-09 MX MX2020010621A patent/MX2020010621A/es unknown
- 2019-04-09 AU AU2019253193A patent/AU2019253193B2/en active Active
- 2019-04-09 US US16/379,322 patent/US10828351B2/en active Active
- 2019-04-09 WO PCT/EP2019/058980 patent/WO2019197414A1/en not_active Ceased
- 2019-04-09 KR KR1020207032300A patent/KR102869640B1/ko active Active
- 2019-04-09 CR CR20200533A patent/CR20200533A/es unknown
- 2019-04-09 PE PE2020001520A patent/PE20201344A1/es unknown
- 2019-04-09 MY MYPI2020005251A patent/MY206040A/en unknown
- 2019-04-09 KR KR1020257033159A patent/KR20250153304A/ko active Pending
- 2019-04-09 IL IL277851A patent/IL277851B2/en unknown
- 2019-04-09 BR BR112020020660-1A patent/BR112020020660A2/pt active Search and Examination
-
2020
- 2020-10-07 CL CL2020002586A patent/CL2020002586A1/es unknown
- 2020-10-09 PH PH12020551670A patent/PH12020551670A1/en unknown
- 2020-11-06 US US17/091,553 patent/US12005102B2/en active Active
- 2020-11-10 CO CONC2020/0013977A patent/CO2020013977A2/es unknown
-
2024
- 2024-04-30 US US18/650,535 patent/US20240350598A1/en active Pending
-
2025
- 2025-01-31 JP JP2025015003A patent/JP2025084745A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025084745A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2013181034A5 (enExample) | ||
| JP2009191078A5 (enExample) | ||
| JP5775451B2 (ja) | インフルエンザを処置するための組成物および方法 | |
| JP2007505033A5 (enExample) | ||
| WO2000032228A2 (en) | Peptide-based vaccine for influenza | |
| JP2009544614A5 (enExample) | ||
| De Haan et al. | Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice | |
| AU2019253193B2 (en) | Anti-abeta therapeutic vaccines | |
| JP7403733B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| JP2023052092A (ja) | 免疫原性組成物 | |
| JP2020534874A (ja) | Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン | |
| JP2015529677A5 (enExample) | ||
| US9821046B2 (en) | Composition and uses thereof | |
| US10286062B2 (en) | Universal influenza vaccine | |
| CL2021003051A1 (es) | Terapia de vacuna anti-abeta. | |
| JP2021524280A (ja) | ハウスダストダニアレルギーの処置および予防 | |
| JP2015525794A5 (enExample) | ||
| CN102365095B (zh) | 分裂gp41 | |
| JP5473899B2 (ja) | 合成ペプチドを含有する抗原薬物ビークルとこれを用いる粘膜ワクチン | |
| US11185583B2 (en) | Multi-functional mucosal vaccine platform | |
| CA3076263C (en) | Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv) | |
| Kramp et al. | Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines | |
| JP2018505697A5 (enExample) |